Search

Displaying results 4031 - 4040 of 5451 in total
  1. Drug

    Pumice

    go.drugbank.com/drugs/DB14374
    Investigational

    It is not an approved drug.

  2. Drug

    Peracetic acid

    go.drugbank.com/drugs/DB14556
    Investigational

    It has an acrid odor and is used as a disinfectant.

  3. Drug

    Bevacizumab zirconium Zr-89

    go.drugbank.com/drugs/DB14907
    Investigational

    Bevacizumab zirconium Zr-89 is under investigation in clinical trial NCT01338090 (89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors).

  4. Drug

    EF-022

    go.drugbank.com/drugs/DB17768
    Investigational

    EF-022 is a modified version of vitamin D binding protein macrophage activator, with potential antineoplastic and anti-angiogenic activities.

    Synonyms: EF 022
  5. Drug

    CSIC002

    go.drugbank.com/drugs/DB18584
    Experimental

    It is being investigated for the treatment of anterior ischemic optic neuropathy.

  6. Drug

    ORM-13070 C-11

    go.drugbank.com/drugs/DB15324
    Investigational

    ORM-13070 C-11 is under investigation in clinical trial NCT00735774 (Suitability of 11C-ORM-13070 as a PET Tracer).

  7. Drug

    ORE-1001

    go.drugbank.com/drugs/DB12271
    Investigational

    It is an ACE2 inhibitor.

  8. Drug

    Etrolizumab

    go.drugbank.com/drugs/DB12189
    Investigational

    Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is typified by a chronic gastrointestinal inflammatory microenvironment, driven in part by the excessive infiltration and retention of intestinal-homing ...

  9. Drug

    IGN101

    go.drugbank.com/drugs/DB06500
    Experimental

    It consists of 500 ug 17-1A antibody adsorbed on aluminum hydroxide.

  10. Drug

    Lemuteporfin

    go.drugbank.com/drugs/DB04980
    Investigational

    It is intended for the treatment of beign prostatic hyperplasia.